← Back to Search

Community Health Worker Program for Lung Cancer Screening

Phase < 1
Waitlist Available
Led By Jennifer Leng, MD, MPH
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial will test if a Community Health Worker program can improve at-risk NYC Chinese community members' participation in shared decision making and lung cancer screening, compared to written materials.

Who is the study for?
This trial is for Chinese community members in NYC who are at risk for lung cancer. It includes male professional drivers aged 50-80, fluent in Mandarin or Cantonese, with a history of heavy smoking. Healthcare providers and livery staff fluent in English or Mandarin can also participate. Participants must not plan to leave the New York area for extended periods during the study.Check my eligibility
What is being tested?
The study tests if a Community Health Worker program improves participation in lung cancer screening and decision-making compared to just providing written materials. The methods include surveys, navigation assistance, focus groups, and interviews among eligible participants.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like surveys and interviews rather than drugs or medical procedures, there are no direct physical side effects expected from participating.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
(Pilot Phase) Increased uptake in SDM and LCS
(Pre-Pilot Phase) Increased uptake in SDM and LCS

Trial Design

5Treatment groups
Experimental Treatment
Active Control
Group I: Pre-pilot GroupExperimental Treatment2 Interventions
Approximately 10 Chinese livery drivers who smoke or who quit smoking with the past 15 years and have a 30 pack-year history of smoking
Group II: Pilot RCT CHW Intervention GroupExperimental Treatment2 Interventions
Eligible NYC Chinese livery drivers will receive written materials and navigation for shared decision making (SDM) and lung cancer screening (LCS).
Group III: In-Depth Interview GroupExperimental Treatment1 Intervention
12-15 in-depth interviews with livery base management and staff, and with 12-15 primary care physicians (PCPs), clinic directors, hospital CFOs, heads of financial services and counseling, and heads of radiology facilities serving the Chinese community.
Group IV: Focus GroupExperimental Treatment1 Intervention
The investigators conducted a series of 4-6 focus groups with Chinese livery drivers who (currently, or in the past) smoke.
Group V: Pilot RCT Control GroupActive Control1 Intervention
Eligible NYC Chinese livery drivers will receive written materials only
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Surveys
2020
Completed Phase 1
~11070
Navigation
2013
Completed Phase 4
~3660
Focus groups
2017
N/A
~340
In-depth interviews
2020
N/A
~90

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,933 Previous Clinical Trials
585,521 Total Patients Enrolled
Jennifer Leng, MD, MPHPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
5 Previous Clinical Trials
2,257 Total Patients Enrolled

Media Library

Navigation Clinical Trial Eligibility Overview. Trial Name: NCT02914899 — Phase < 1
Lung Cancer Screening Research Study Groups: Pilot RCT Control Group, Pilot RCT CHW Intervention Group, Focus Group, In-Depth Interview Group, Pre-pilot Group
Lung Cancer Screening Clinical Trial 2023: Navigation Highlights & Side Effects. Trial Name: NCT02914899 — Phase < 1
Navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT02914899 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this clinical experiment open to me?

"This clinical trial is admitting 174 individuals of Chinese descent, aged 21 and above and fluent in Mandarin. Other prerequisites include being a livery driver between 45-80 years old who have either currently or formerly (within 15 years) smoked cigarettes; certain Livery staff, base owners or employees may also be eligible for an In Depth Interview."

Answered by AI

Does this investigation accept participants older than 25 years?

"The minimum age for participation in this trial is 21 and the maximum age that will be accepted is 80."

Answered by AI

Is there availability in this trial for new participants?

"Unfortunately, this clinical trial is not currently accepting new participants. It was first posted on August 1st 2016 and last updated July 14th 2022. Fortunately, there are many other studies actively recruiting patients at the moment; data hosted by clinicialtrials.gov shows that over 1400 trials are open for enrollment right now."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community
2016. "Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02914899.
~0 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top